CapsoVision (CV) Return on Assets (2025)
CapsoVision (CV) reported Return on Assets of 0.01% for Q4 2025, up 14.07% sequentially from 0.01% in Q3 2025.
CapsoVision (CV) Return on Assets (2025) Analysis & Trends
CapsoVision (CV) has 1 years of Return on Assets data on file, last reported at 0.01% in Q4 2025.
- For the quarter ending Q4 2025, Return on Assets changed N/A year-over-year to 0.01%; the trailing twelve-month figure through Dec 2025 stood at 0.01% (changed N/A YoY), and the FY2025 full-year result was 0.01%, changed N/A from the prior year.
- Return on Assets improved to 0.01% in Q4 2025, from 0.01% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.01% in Q4 2025 to a low of 0.02% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.44 Bn | 175.14 Bn | 6.27 Bn | 0.00% |
| 2 | Stryker | 128.91 Bn | 126.03 Bn | 3.81 Bn | 0.00% |
| 3 | Medtronic | 108.67 Bn | 99.45 Bn | 6.41 Bn | 0.00% |
| 4 | Boston Scientific | 68.45 Bn | 67.00 Bn | 3.61 Bn | 0.00% |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn | 0.00% |
| 6 | Dexcom | 28.59 Bn | 27.48 Bn | 750.30 Mn | 0.00% |
| 7 | GE HealthCare Technologies | 28.53 Bn | 26.24 Bn | 1.98 Bn | 0.00% |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | 0.00% |
| 9 | Koninklijke Philips | 25.42 Bn | 22.30 Bn | 2.07 Bn | 0.00% |
| 10 | CapsoVision | 164.77 Mn | 154.65 Mn | 1.95 Mn | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | -0.02% |